Keymed Biosciences, Inc.'s market cap is currently HK$9.83B. The company's EPS TTM is HK$-3; its P/E ratio is ―; Keymed Biosciences, Inc. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 354.10M	¥ 100.06M	¥ 110.27M	¥ 0.00	¥ 0.00
Gross Profit	¥ 317.22M	¥ 97.48M	¥ 93.07M	¥ 0.00	¥ 0.00
Operating Income	¥ -434.80M	¥ -295.38M	¥ -3.88B	¥ -804.70M	¥ -162.20M
EBITDA	¥ -269.77M	¥ -259.25M	¥ -3.86B	¥ -785.71M	¥ -71.83M
Net Income	¥ -359.36M	¥ -308.12M	¥ -3.90B	¥ -832.73M	¥ -172.83M
Balance Sheet
Cash & Short-Term Investments	¥ 2.72B	¥ 3.18B	¥ 3.52B	¥ 354.08M	¥ 498.95M
Total Assets	¥ 3.88B	¥ 3.93B	¥ 3.93B	¥ 529.95M	¥ 658.58M
Total Debt	¥ 418.71M	¥ 121.97M	¥ 39.26M	¥ 66.86M	¥ 76.45M
Net Debt	¥ -432.32M	¥ -482.10M	¥ -1.48B	¥ -132.54M	¥ -356.16M
Total Liabilities	¥ 896.11M	¥ 593.10M	¥ 289.07M	¥ 1.62B	¥ 934.53M
Stockholders' Equity	¥ 2.99B	¥ 3.34B	¥ 3.65B	¥ -1.09B	¥ -275.95M
Cash Flow
Free Cash Flow	¥ -686.23M	¥ -681.48M	¥ -387.50M	¥ -139.26M	¥ -130.68M
Operating Cash Flow	¥ -303.62M	¥ -401.93M	¥ -214.64M	¥ -119.36M	¥ -68.38M
Investing Cash Flow	¥ 468.20M	¥ -645.59M	¥ -2.04B	¥ -113.07M	¥ -58.02M
Financing Cash Flow	¥ 72.13M	¥ -8.06M	¥ 3.64B	¥ 7.40M	¥ 505.07M

Currency in CNY

Keymed Biosciences, Inc. Earnings and Revenue History

Income Statement >

Keymed Biosciences, Inc. Debt to Assets

Balance Sheet >

Keymed Biosciences, Inc. Cash Flow

Cash Flow >

Keymed Biosciences, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing